Figure 3 (Figure0002)
Ivabradine Tablet, Film Coated
Product Images NDC 69452-191
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ivabradine (NDC 69452-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 4 (Figure0003)
Figure 2 (Figure001)
This text provides information on the recommended change in medication doses due to PK measures, specifically focusing on the impact of CYP3A4 inhibitors and inducers. It lists various drugs categorized as strong, moderate, or other inhibitors or inducers, along with the corresponding dosage adjustments or recommendations to avoid use. Additionally, it mentions specific medications like Ivabradine and highlights the change relative to it when used alone. This data is presented alongside confidence intervals for accuracy.*
5 mg 60's Label (Image001)
This text appears to be a description of medication related information, including details about Ivabradine Tablets, recommended dosage, prescription information, and packaging details. It also mentions a pharmacist dispensing the accompanying medication guide to each patient. The text provides information on the number of film-coated tablets, manufacturer details, and identification numbers.*
5 mg 500's Label (Image002)
This text provides information on Ivabradine Tablets, with each film-coated tablet containing 5 mg of Ivabradine. The recommended dosage instructions are not visible in the given text, but it advises to dispense the Medication Guide to each patient and to keep the tablets out of reach of children. The tablets are to be stored at 25°C with excursions permitted to 15-30°C. The product is distributed by Bonpharma from Princeton, NJ, USA, and is manufactured in India. The text also includes a GTIN, Lot, and Expiry information.*
7.5 mg 60's Label (Image003)
This text provides information about Ivabradine Tablets by BIONPHARMA. The tablets contain 7.5 mg of Ivabradine equivalent to 8.085 mg of Ivabradine as hydrochloride. Each package contains 60 film-coated tablets with a recommended dosage and storage instructions. It also mentions the manufacturer as Bonpharma and indicates that the tablets are made in India. The lot number, expiration date, and serial number are included for tracking purposes.*
7.5 mg 500's Label (Image004)
Each film-coated tablet contains 7.5 mg of Ivabradine, equivalent to 8.085 mg of Ivabradine hydrochloride. These tablets are recommended for use as per prescribing information. The medication should be stored at 25°C (77°F) with excursions permitted to 15° to 30°C (59° to 86°F) as per USP Controlled guidelines. It is advised to keep the medication out of sight and reach of children. The accompanying Medication Guide should be dispensed to each patient. This product is for prescription use only and includes 500 film-coated tablets. Also, the company mentioned is Sinopharma and the product is made in India.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
